B Alert
Researchers explore the dangers of hepatitis B and HIV coinfection
by Larry Buhl
New research suggests people with chronic hepatitis B virus (HBV) infection have twice...
Care Costs
LifeGuide
New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge
by Larry Buhl
This column has covered several antiviral meds in...
Dos & Dont’s
Hep C Is Manageable—If You Know the Ins and Outs
by Larry Buhl
You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...
Going Viral
While federal efforts move forward, hepatitis prevention remains unfunded
by Larry Buhl
During the seemingly interminable debate over health insurance reform, other health legislation was quietly...
Be Smart
In an Effort to Prevent HCV, One Campaign Is Educating Youth on Body Art Risks
by Larry Buhl
In the U.S., an estimated thirty-six percent of...
Clearing Hurdles
What can we do to address the obstacles to HCV treatment?
by Larry Buhl
Hepatitis C (HCV) is a “silent killer” in more ways than one....
REALIZE Gets Real
Hep Talk
Hepatitis C Antiviral Telaprevir Moves Closer to Approval
by Larry Buhl
Researchers in a recent Phase III study are encouraged by the results of a...
LATEST POSTS
AIDS Foundation Chicago: Free Webinars Exploring Racism in HIV & Public...
A&U is pleased to share this press release with you.
AIDS Foundation Chicago hosts free webinars exploring racism in HIV and public health industries
WHAT: ...
